Cargando…
Localized Delayed T-cell Mediated Hypersensitivity After mRNA SARS-CoV-2 Vaccination
Since the emergency authorization of SARS-CoV-2 vaccines, the medical literature has been investigating the management of allergic reactions to the vaccines. Anaphylaxis has been reported among a minority of vaccinated individuals, and many trials monitoring the safety profile of the vaccines have i...
Autores principales: | Jhawar, Nikita, Cardenas Rosales, Juan, Gonzalez-Estrada, Alexei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035941/ https://www.ncbi.nlm.nih.gov/pubmed/36968947 http://dx.doi.org/10.7759/cureus.35271 |
Ejemplares similares
-
Assessing delayed penicillin hypersensitivity using the PENFAST+ score
por: Castagna, Julie, et al.
Publicado: (2023) -
Clinical Analysis and Applications of mRNA Vaccines in Infectious Diseases and Cancer Treatment
por: Ankrah, Paa Kwesi, et al.
Publicado: (2023) -
Use of Rapid Drug Desensitization in Delayed Hypersensitivity Reactions to Chemotherapy and Monoclonal Antibodies
por: Vega, Arantza, et al.
Publicado: (2022) -
SARS-CoV-2 vaccine excipients polyethylene glycol and trometamol do not induce mast cell degranulation, in an in vitro model for non-IgE-mediated hypersensitivity
por: Quan, Paola Leonor, et al.
Publicado: (2022) -
Polyarteritis Nodosa Following mRNA-1273 COVID-19 Vaccination: Case Study and Review of Immunological Mechanisms
por: Srichawla, Bahadar S
Publicado: (2023)